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Abstract
In the early stages of breast cancer metastasis, epithelial cells penetrate the basement membrane and invade the
surrounding stroma, where they encounter fibroblasts. Paracrine signaling between fibroblasts and epithelial tumor cells
contributes to the metastatic cascade, but little is known about the role of adhesive contacts between these two cell types
in metastasis. Here we show that MCF-7 breast cancer epithelial cells and normal breast fibroblasts form heterotypic
adhesions when grown together in co-culture, as evidenced by adhesion assays. PCR and immunoblotting show that both
cell types express multiple members of the cadherin superfamily, including the atypical cadherin, cadherin-23, when grown
in isolation and in co-culture. Immunocytochemistry experiments show that cadherin-23 localizes to homotypic adhesions
between MCF-7 cells and also to heterotypic adhesions between the epithelial cells and fibroblasts, and antibody inhibition
and RNAi experiments show that cadherin-23 plays a role in mediating these adhesive interactions. Finally, we show that
cadherin-23 is upregulated in breast cancer tissue samples, and we hypothesize that heterotypic adhesions mediated by
this atypical cadherin may play a role in the early stages of metastasis.
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Introduction
Fibroblasts are the most abundant cell type found in the stroma
surrounding glandular epithelial tissues. Ample evidence indicates
that fibroblasts can promote epithelial tumor progression via
paracrine signaling, but direct contact with invading tumor cells
may affect tumorigenesis and metastasis as well [1]. Recent
evidence has shown that fibroblasts and epithelial cells can form
heterotypic cell-cell adhesions in vitro, and that cadherin adhesion
molecules are recruited to these heterotypic adhesions [2].
Metastatic tumor cells often show changes in cadherin
expression [3]. Many tumor cells undergo a ‘‘cadherin switch’’
in which E-cadherin expression decreases and N-cadherin
expression increases, although changes in other cadherins may
also be observed. These changes in cadherin expression are
associated with the decreased adhesion and increased motility
characteristic of metastatic disease [4–6].
Cadherin-23 is an atypical cadherin implicated in several
deafness syndromes due to its role as a component of the tip link
complex between stereocilia in cochlear hair cells [7,8]. It has up
to 27 extracellular cadherin repeats (ECs) (Fig. S1A) [9] and a
unique cytoplasmic domain that interacts indirectly with the actin
cytoskeleton [10]. Although the N-terminal EC (EC1) differs
sufficiently from that of classical cadherins to warrant the
classification of cadherin-23 as a cadherin-related protein [7,11],
biochemical and structural data suggest that cadherin-23 can form
Ca
2+-dependent homophilic adhesions through its EC1 [12].
Several isoforms, differing in size, EC number, tissue and
developmental expression, have been described, although little is
known about the functional significance of these isoforms [13,14].
Here we sought to determine if breast cancer epithelial cells
can make heterotypic cell-cell adhesions with normal fibroblasts
and to test whether members of the cadherin superfamily
mediate these interactions. We found that MCF-7 breast cancer
cells and normal breast fibroblasts (NBFs) form heterotypic
adhesions in a co-culture model of the tumor microenvironment,
and we found that an atypical member of the cadherin
superfamily, cadherin-23, localizes to sites of heterotypic contact.
We also found that disruption of cadherin-23 expression or
function decreases both homotypic adhesion between epithelial
cells and heterotypic adhesion between epithelial cells and
fibroblasts. Finally, we show that cadherin-23 is up-regulated in
breast cancer tissue versus normal tissue and we propose that
cadherin-23-mediated heterotypic adhesion between invading
tumor cells and stromal fibroblasts may play a role in the
metastatic cascade.
Results and Discussion
MCF-7s and NBFs form heterotypic adhesions in vitro
To determine if MCF-7 cells and NBFs can form heterotypic
cell-cell adhesions, we developed a co-culture system in which we
grew cells together for up to three days. To distinguish between
the two cell types after co-culture, we either pre-labeled one or
both cell types with CellTracker
TM dyes before co-culture
(Fig. 1A, C), and/or fixed the cultures and performed immu-
nocytochemistry with antibodies to cell-type-specific intermediate
filaments (cytokeratin-8 for MCF-7s (Fig. 1A, B) and vimentin for
NBFs (data not shown)) [15,16]. We also used an antibody to b-
catenin to identify sites of possible cell-cell adhesion, as b-catenin
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33289is a cytoplasmic partner of many cadherin family members
(Fig. 1B). We found that when MCF-7s and NBFs were in close
proximity, they extended cytoplasmic processes to make contact
with one another (Fig. 1A, B, arrows). We scored these contacts
for b-catenin recruitment and found it at 82.1% of heterotypic
contacts (n=451, Fig. 1B, arrow). We also noted that both cell
types retained their distinct morphologies in co-culture (i.e.
fibroblasts are long, spindle-shaped cells, while MCF-7s are more
round and compact), and these characteristic phenotypes were
used to aid in distinguishing cell types in some subsequent
experiments.
We then performed adhesion assays to test the strength of these
interactions. Each cell type was pre-labeled with a CellTracker
TM
dye (Green or Red), then equal numbers of epithelial cells and
fibroblasts were combined in agarose-coated wells (to prevent cell-
surface adhesion). After one hour of rotating incubation, cell
aggregates were counted (n=515) and scored for the presence of
each cell type. 47.2% of the aggregates contained both cell types
(Fig. 1C), suggesting that MCF-7s and NBFs can form heterotypic
adhesions in a simplified system in which the role of cell:ECM
adhesion is minimized.
Both MCF-7s and NBFs express cadherin-23
We hypothesized that the heterotypic adhesion we observed
may be mediated by cadherins, so we screened cells cultured alone
as well as co-cultured cells by PCR for expression of cadherin
family members (Table S1). As expected, MCF-7s express
epithelial cadherins such as E- and P-cadherin and NBFs express
fibroblast cadherins such as N- and OB-cadherin, and all these
cadherins were also expressed in co-cultures (Table S1). Surpris-
ingly, the atypical cadherin-23 was also expressed by both cell
types alone and in co-cultures (Table S1, Fig. S1B).
As the expression of cadherin-23 has only previously been
reported in the neurosensory epithelium, we confirmed its
expression with two independent PCR primer sets and then
cloned and sequenced the PCR products of the MCF-7
monocultures and the 3-day co-cultures, and found that they
were .99% identical to cadherin-23 (via BLAST comparison). We
noted that the expression of cadherin-23 was typically lower in
fibroblasts than in the MCF-7 cells, which we confirmed with
qPCR (Fig. S1D). We then confirmed cadherin-23 protein
expression with immunoblotting (Fig. S1C), and found that two
major isoforms (,70 and ,130 kD) were expressed both by
Figure 1. MCF-7s and NBFs form heterotypic adhesions and express cadherin-23 in vitro. A) NBFs were pre-labeled with CellTracker
TM
Green and co-cultured with MCF-7s for 3 days. Cells were then fixed and labeled with an antibody against cytokeratin-8 (red). Arrow shows a site of
heterotypic contact between the two cell types. B) Three-day co-cultures labeled with antibodies against b-catenin (red) and cytokeratin-8 (green).
Arrow – heterotypic contact; Arrowhead – MCF-7 homotypic contact. Scale=10 mm. C) MCF-7s labeled with CellTracker Green
TM (arrowhead) were
co-cultured with NBFs labeled with CellTracker Red
TM (arrow). Phase contrast (left) and fluorescence image (right) of a typical heterotypic cell
aggregate are shown. Scale=20 mm. D) Immunoblots show no vimentin expression in MCF-7 fraction and no cytokeratin-8 in NBF fraction after FACS
separation of co-cultures. PCR (E) and immunoblots (F) showing cadherin-23 expression in MCF-7s and NBFs before and after co-culture. a-tubulin
and GAPDH were used as controls.
doi:10.1371/journal.pone.0033289.g001
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expression of the longest predicted isoform, and the MCF-7s
consistently showed higher cadherin-23 protein expression than
NBFs (Fig. S1C). Together, these data suggest that cadherin-23 is
expressed by both cell types alone and in co-cultures, but that the
protein is expressed at higher levels in epithelial cells than in
fibroblasts.
To verify that cadherin-23 is expressed by each cell type in co-
culture, we separated co-cultured cells using FACS after first
labeling one cell type with CellTracker
TM. Efficient separation was
confirmed using cytokeratin-8 and vimentin immunoblotting
(Fig. 1D). We then probed the separated cell populations for
cadherin-23 expression and compared it to the levels found in
mono-cultures and found that for each cell type, cadherin-23
expression levels were similar in mono- and co-cultures (Fig. 1E,
F).
Cadherin-23 localizes to homotypic and heterotypic
contact sites
To determine if the cadherins expressed were localized to
homotypic and/or heterotypic contact sites, we performed
immunocytochemistry on mono- and co-cultures with antibodies
to each cadherin in combination with an antibody to b-catenin
which marked possible cell-cell adhesion sites (Fig. S2, Fig. 2). As
expected, E- and N-cadherin were robustly localized at homotypic
adhesions between MCF-7s and NBFs, respectively (Fig. S2A, B,
arrows). Both cadherins also localized to heterotypic contacts, but
neither labeled the entire contact site (Fig. S2A, B, arrowheads). P-
and OB-cadherin localized to homotypic adhesions between
MCF-7s and NBFs, respectively, but not to heterotypic contacts
(Fig. S2C, D).
Cadherin-23 was not localized at homotypic adhesions between
NBFs, but was found at 75.4% of homotypic adhesions between
MCF-7s (n=61 cell pairs) (Fig. 2A, B). It was typically found at
contacts between cells in the interior of the epithelial cell island,
but was often absent from contacts at the island boundary (Fig. 2A,
arrow). Cadherin-23 localized to 23% of heterotypic contacts
between MCF-7s and NBFs two hours after co-culturing (Fig. 2C,
arrowhead), and by 3 days was found at 45% of heterotypic cell
pairs (Fig. 2D, arrowhead) (n=40 and n=100 cell pairs,
respectively). These results suggest that E- and N-cadherin, as
well as cadherin-23 are localized at heterotypic contacts, where
they may play a role in heterotypic adhesion.
In NBFs, antibodies to cadherin-23 also showed a prominent
localization to centrosomes (Fig. 2B), where they co-localized with
an antibody to c-tubulin (data not shown). Cadherin-23 has
previously been shown to localize to centrosomes in the early
stages of inner ear hair cell development [13], but the
physiological significance of this localization is unclear.
Cadherin-23 participates in MCF-7 homotypic and
heterotypic adhesion
To determine if cadherin-23 plays a role in adhesion, we
performed adhesion assays after disruption of cadherin-23 with
inhibitory antibodies or after knockdown of the protein by RNAi.
To disrupt cadherin-23 function, we used an antibody to
cadherin-23 EC1, which is thought to be the primary adhesion
domain [11,12]. As a positive control for MCF-7 homotypic
adhesion, we used an antibody to E-cadherin EC1, which
interferes with E-cadherin mediated adhesion [17]. As a negative
control for MCF-7 homotypic adhesion, we used an antibody to
OB-cadherin which disrupts adhesion in OB-cadherin expressing
cells [18], but would not be expected to have an effect in MCF-7s
as they do not express the protein. As a negative control for
heterotypic adhesion, we used a no-antibody treatment. We
performed the adhesion assays as described above and measured
the increase in cell aggregates between plating and 2 hours of
rotating incubation.
Both the E-cadherin and the cadherin-23 antibodies individu-
ally and in combination significantly reduced MCF-7 homotypic
aggregation after two hours in comparison to the OB-cadherin
antibody (Fig. 3A, top panel) or no antibody (data not shown),
suggesting that both proteins may play a role in epithelial cell-cell
adhesion. The cadherin-23 antibody shows no reactivity to E-
cadherin by immunocytochemistry or immunoblotting (data not
shown), and the effects of the E-cadherin and cadherin-23
antibodies in combination is greater than that of either alone,
suggesting that the effect of the cadherin-23 antibody is not merely
due to non-specific interaction with E-cadherin. Neither the E-
cadherin antibody nor the cadherin-23 antibody affected NBF
homotypic cell aggregation (data not shown), presumably because
neither protein is localized at NBF homotypic contact sites (Fig. 2B
and data not shown).
To test the role of cadherin-23 in heterotypic adhesion, we pre-
labeled the two cell populations with different CellTracker
TM dyes
(Green and Red), performed adhesion assays as above, and then
compared the number of MCF-7/NBF heterotypic aggregates to
NBF homotypic aggregates. We used the number of NBF
homotypic aggregates as a standard because they were not
affected by either antibody treatment (above). Cadherin-23-
antibody incubation inhibited heterotypic adhesion while the E-
cadherin antibody alone did not affect heterotypic adhesion
(Fig. 3A, bottom panel). Both antibodies combined did not show
any additional effect.
To verify the results of the antibody inhibition experiments, we
knocked down cadherin-23 expression in MCF-7 cells using
RNAi, as evidenced by RT-PCR and immunoblotting (Fig. 3B)
and then performed adhesion assays as described above. As the
shRNA plasmids also coded for a green fluorescent protein, we
used CellTracker Red
TM to label the NBFs. RNAi knockdown of
cadherin-23 significantly affected the ability of MCF-7 cells to
participate in both homotypic and heterotypic adhesion, consistent
with the results obtained from the antibody inhibition experiments
(Fig. 3C). Typical homotypic and heterotypic cell aggregates
shown in Fig. 3D–E. Both types of cell aggregates from cells
expressing cadherin-23 (NC) are consistently much larger than
those in which cadherin-23 expression is decreased (KD).
Together, these data suggest that both E-cadherin and cadherin-
23 play a role in MCF-7 homotypic adhesion, but that only
cadherin-23 and not E-cadherin has a role in heterotypic
adhesion.
In the inner ear stereocilia, protocadherin-15 is thought to be
the binding partner for cadherin-23 [19]. However, we failed to
detect protocadherin-15 expression in MCF-7s, NBFs or co-
cultures (data not shown). Cadherin-cadherin binding is highly
class specific because of the strand-swapping between cadherin
domains. It has been suggested that cadherin-23 can participate in
homophilic adhesion, but the mechanism is likely to differ from
that of classical cadherins because of structural differences between
the cadherin domains [11,12]. Therefore, although E- and N-
cadherin partially co-localize with cadherin-23 at heterotypic
adhesions, it is unlikely that they can serve as heterophilic binding
partners with cadherin-23. Our evidence that the E-cadherin
antibody did not affect heterotypic adhesion supports this
hypothesis, and therefore, we think it most likely that heterotypic
adhesion between tumor cells and fibroblasts is mediated by
cadherin-23 homophilic adhesion.
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carcinoma tissues
To determine whether cadherin-23 may play a role in human
breast cancer, we labeled a breast cancer tissue microarray with
cadherin-23 antibodies. Samples were blindly scored for overall
level of cadherin-23 expression and tumor samples showed
significantly higher cadherin-23 expression than healthy tissue
(Fig. 4A, top panel). Increased cadherin-23 expression was seen in
both epithelial and stromal cells in cancer samples (Fig. 4A, middle
and bottom panels and B–C). In both tumor and healthy samples,
cadherin-23 expression was higher in luminal epithelia than in
stroma, consistent with the higher cadherin-23 expression we
observed in MCF-7s compared to NBFs (Fig. 4B–C, S1B–C).
Interestingly, we often observed strong stromal tissue labeling
adjacent to intensely stained luminal tissue in many disease
samples, but not in healthy breast tissue (Fig. 4B–C, arrow).
Figure 2. Cadherin-23 localizes to homotypic and heterotypic contacts. Cadherin-23 localizes at 75% of homotypic contacts between MCF-
7s (arrowhead, A) but not NBFs (B). Arrow in (A) points to a contact between MCF-7s without cadherin-23 recruitment. Cadherin-23 localizes at 23% of
heterotypic adhesions in two-hour (C) and 45% of three-day (D) co-cultures (arrowhead). Asterisks in (C–D) mark fibroblasts. Fig. 2C shows MCF-7 cells
and NBFs co-cultured for two hours, where a group of spherical MCF-7 cells is on top of a flat and extended fibroblast (asterisk). One of the MCF-7
cells has formed a possible adhesion site with the fibroblast, as evidenced by b-catenin labeling, and cadherin-23 has already been recruited at that
site (arrowhead). Fig. 2D shows a group of compact MCF-7 cells, where one of them has formed an adhesion site with an extended fibroblast
(asterisk), as marked by b-catenin localization, where cadherin-23 has been recruited (arrowhead). All images are maximum projections of confocal z-
stacks. Scale=10 mm.
doi:10.1371/journal.pone.0033289.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33289Figure 3. Cadherin-23 plays a role in homotypic and heterotypic adhesion. A) Adhesion assays using inhibitory antibodies. Top panel: the
percent of total MCF-7 cell aggregates comprised of 3 or more cells was measured at t=0 and at t=2 hrs and the change in this percentage was
calculated. Cadherin-23 and E-cadherin antibodies, individually and in conjunction, showed a statistically significant reduction of adhesion when
compared to the effect of an antibody that blocks OB-cadherin-mediated adhesion. (n=3 independent experiments; one tail unpaired t-test; asterisks
mark statistically significant differences). Bottom panel: adhesionassays on 1:1 mixture of MCF-7:NBF after 2 hrs. Theantibody against cadherin-23, both
alone and in conjunction with the E-cadherin antibody, significantly reduced heterotypic adhesion. (n=6 independent experiments; one tail unpaired t-
test; asterisks mark statistically significant differences; NS=not significant). B) RNAi knock down of cadherin-23 in MCF-7 cells, as evidenced by both RT-
PCR (left panel) and immunoblotting (right panel). In the left panel, 25 ng of mRNA were used for each PCR reaction, and the entire product was run on
the agarose gel. NC: non-coding RNAi sequence; KD: cadherin-23 specific RNAi sequence. C) Adhesion assays, as in panel 3A, but after RNAi knock down
of cadherin-23 in MCF-7 cells. Toppanel: RNAi treatment significantly reduced the ability of MCF-7 cells to participate in homotypic adhesion. (n=3; one
tail unpaired t-test; asterisks mark statistically significant differences). Bottom panel: RNAi treatment significantly reduced the number of heterotypic
aggregates after 2 hrs. (n=3; one tail unpaired t-test; asterisks mark statistically significant differences). D) Representative image of MCF-7 cell
aggregates aftertreatment with RNAi.Scale=100 mm.E)Representative imageofMCF-7:NBFcell aggregates after treatment with RNAi.shRNAplasmids
contained a gene to a green fluorescent protein, while NBFs were labeled with CellTracker
TM Red. Hoescht dye was used to stain the nuclei.
doi:10.1371/journal.pone.0033289.g003
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human ductal epithelial cells, is up-regulated in human breast
cancer and further that the increased stromal labeling may serve to
mediate heterotypic adhesion between invading tumor cells and
stromal fibroblasts.
Cadherin-23 may be involved in signaling as well. Cadherin-23
belongs to the cadherin-related-2 subfamily [7] and it has a
cytoplasmic PDZ binding motif [20,21]. Another member of the
same subfamily with a PDZ-binding motif, protocadherin-24, has
been shown to play a role in regulating contact inhibition [22].
Cadherin-23 is also 80% similar to Fat1, a cadherin with roles in
tumor suppression and planar cell polarity [23,24]. We observed
that in confluent MCF-7s, cadherin-23 is localized to all cell
contacts, but in sub-confluent cultures, peripheral cell adhesions
usually lack cadherin-23 (Fig. 2A). These results suggest that
cadherin-23 may play a role in contact inhibition or planar cell
polarity, but further experiments will be necessary to elucidate this
role.
Materials and Methods
Cell Culture
MCF-7s and NBFs (CCD-1065SK) from ATCC (Manassas,
VA, USA) were grown in MEM/EBSS (Hyclone, Logan, UT,
USA) containing 2 mM L-glutamine (Hyclone), 10% FBS (Atlanta
Biologicals, Laurensville, GA, USA), 1 mM Na-Pyruvate (Sigma,
St. Louis, MO, USA) and 100 mg/ml Penicillin/Streptomycin
(Hyclone). MCF-7 and co-culture media also contained insulin
(0.01 and 0.005 mg/ml, respectively) (GIBCO, Carlsbad, CA,
USA). We verified that each cell type grew equally well in co-
Figure 4. Cadherin-23 is upregulated in breast cancer. Samples from breast cancer (n=58, including both in situ and invasive carcinomas) and
healthy breast tissue (n=8) were labeled with cadherin-23 antibodies and blindly scored for overall (top panel), stromal (middle panel) and epithelial
(bottom panel) cadherin-23 labeling (‘2’: no expression; ‘+’: low expression; ‘++’: high expression) (A). In all cases carcinoma samples showed
significantly higher expression (Wilcoxon Rank-Sum test, p=0.01). Representative carcinoma (in situ) (B) (scored as ‘++’) and normal breast (C) tissue
(scored as ‘2’) labeled with cadherin-23 antibodies. Arrow in (B) points to a duct with intense cadherin-23 labeling that is budding into the stroma.
Insets in (B–C) show a higher magnification of the enclosed area. Scale=0.1 mm.
doi:10.1371/journal.pone.0033289.g004
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these studies was derived from the mammary skin of a breast
cancer patient after surgery. As such, these fibroblasts are not
cancer-associated or activated, as was evidenced by the absence of
a-smooth-muscle-actin mRNA expression (data not shown).
Although these are skin fibroblasts, they are thought to model
stromal fibroblasts [25].
Immunocytochemistry
Cells were grown on glass coverslips, fixed in anhydrous
methanol containing 1 mM EGTA at 220uC and processed with
b-catenin (Zymed, San Fransisco, CA, USA), cytokeratin-8
(Sigma), vimentin (Sigma), N-cadherin (BD, Franklin Lakes, NJ,
USA), E-cadherin (Chemicon, Billerica, MA, USA), P-cadherin
(R&D Systems, Minneapolis, MN, USA), OB-cadherin (Chemi-
con) or cadherin-23 antibodies (Abnova, Cat. # H00064072-A01,
Taipei City, Taiwan), followed by Alexa Fluor 488 and 594
secondary antibodies (Molecular Probes, Carlsbad, CA, USA) and
DAPI (Invitrogen, Carlsbad, CA, USA) to counterstain the nuclei.
Coverslips were mounted with ProLong (Molecular Probes).
Images were acquired at room temperature using Volocity
(Improvision, Waltham, MA, USA) on a Leica microscope with
a Yokogawa spinning disk, a Plan-Apo 63X 1.3 N.A. glycerol
objective and an ORCA-ER camera (Hamamatsu) or using Zeiss
AIM (Jena, Germany) on a Zeiss LSM 510 confocal microscope
with a Plan-Apo 63X 1.3 N.A. oil objective. Color balance was
adjusted using Adobe Photoshop CS2 (San Jose, CA, USA). The
percentage of adhesion sites that recruited cadherin-23 was
calculated by scoring the possible adhesion sites (which showed
b-catenin localization) for cadherin-23 labeling. For example, in
Fig. 2A, the arrowhead points to an adhesion site that recruits
cadherin-23, while the arrow points to an adhesion site that shows
b-catenin localization, but not that of cadherin-23.
Adhesion Assays
MCF-7s or NBFs (labeled with CellTracker
TM Green or Red
(Invitrogen)) were suspended using CellStripper
TM (Cellgro,
Manassas, VA, USA). Only cultures with ,20% aggregates with
3 or more cells after suspension were used in adhesion assays.
80,000–100,000 cells (of a single type or a 1:1 mixture) were
suspended in Ca
2+-containing HBSS (Hyclone) with 0.02 U/ml
DNAse I (NEB, Ipswich, MA, USA) and Hoescht dye (Sigma), and
added to 1%-agarose-pre-coated tissue culture plates (d=2.5 cm),
which were placed on a rotating shaker (80 rpm) at 37uC. For
MCF-7 adhesion assays, .100 cell aggregates were randomly
chosen and scored for having 3-and-more or ,3 cells. The 3-and-
more cells aggregate percentage change was calculated between
plating and after two hours. For heterotypic adhesion assays, .50
cell aggregates (2 or more cells) were randomly chosen and scored
for cell composition (MCF-7 only, NBF only or MCF7+NBF) after
2 hrs of rotating incubation. The number of MCF7+NBF aggre-
gates was compared to NBF-only cell aggregates (MCF7+NBF/
NBF) (y axis at bottom panels of Fig. 3A, C). Antibody-inhibition
experiments were performed with 1:250 cadherin-23 antibody
(against the EC1 domain, Abnova, Cat. # H00064072-A01),
1:100 E-cadherin antibody (67A4, Millipore, Billerica, MA, USA),
and 1:250 OB-cadherin antibody (R&D Systems, Cat. # AF1790).
The cadherin-23 antibody used did not recognize a band of the
same size as E-cadherin (120 kDa) during immunoblotting
experiments.
RT-PCR
Confluent monocultures of MCF-7s, NBFs, or 1-hour or 3-day
co-cultures were trypsinized and ,20610
4 cells were used for
mRNA isolation (RNEasy, Qiagen, Valencia, CA, USA) for RT-
PCR (Cells-to-Signal, Ambion, Austin, TX, USA). PCR primers
and conditions for E- and N-cadherin were as in [26]. Other
primers were P-cadherin: 59-TCCTCCGCCTCCGACCAA-
GAC-39 and 59-GGCCCAGGCCCAGGACACA-39; R-cadherin:
59-CAAAGTTGGGGCAGATGGGACAGT-39 and 59-GCGT-
GGGCTCGGAGGTGGTAAGA-39; VE-cadherin: 59-CCCGG-
AGTTTGCCAAGCCCTACCA-39 and 59-ATCTCGCCGCC-
GCCCTCCTC-39; K-cadherin: 59-GACAACACGGCGGGAA-
TCT-39 and 59-AAGGAGTCGTATGGCGGGGCAGTG-39;
cadherin 7: 59-CCAGCCGGGGCAGGTTATCCAGA-39 and
59-CTCCCCCGCCCTCGTCATCGTATC-39; cadherin 8: 59-
AAAACCCGGCCAAGTCATTCAA-39 and 59-CTCCCCTCC-
TCCTTCATCATCGTA-39; T1-cadherin: 59-GTGTTGTTTG-
CTGCATTGAAGAGG-39 and 59-TTGAAACGAGGCCCC-
CAGTC-39; T2-cadherin: 59-ACGCGTGGCTGTTTTTGT-
GAGA-39 and 59-GAGGCCGGCAGGGAGGAG-39; OB-cad-
herin: 59-AGCGGCCCTGTGACATTCCTTC-39 and 59-CCT-
GCCCCTCCTTGCCCTTCTCAT-39; N-cadherin 2: 59-TGG-
CGCTGTCACTGCTCAA-39 and 59-CCTGCGGCTGTATC-
CATTTCTT-39; H-cadherin: 59-GCGGAAGATATGGCAGA-
ACTCGTG-39 and 59-CATTATCGGTGGCTGGGTCATC-
TG-39; M-cadherin: 59-CCCTGGACATCGCCGACTTCAT-
CA-39 and 59-GGCCGCCCCATCCACACTCAGGT-39; KSP-
cadherin: 59-CCTCGGCTGGGGGCTCTGG-39 and 59-CGG-
GGGCATCTGCATCCTCTG-39; LI-cadherin: 59-CAAGCGA-
AAGTCAGTGAGGATGTA-39 and 59-ACTGCCGAGGGAA-
AATGTAAAATG-39; cadherin18: 59-ACGCCTGCCTGTAAA-
TCCAAACT-39 and 59-TCTCCGCCTCCTTCATCATCATA-
G-39; cadherin 19: 59-GAACGCAAGACTCGCAAAACC-39 and
59-CCATAGAGCCAGGGCACAAAAC-39; cadherin 20: 59-
GCGGCACCGGAAACAACCATACAT-39 and 59-GCCTGC-
TCACCCCCATTCTCACTC-39; cadherin 22: 59-AGCAGCA-
GCGGCGGCGATGTGTT-39 and 59-CGCGGTCCAGCCCC-
TTGCCAGTC-39; cadherin 23 (EC1): 59-CCGGCTGCCCTT-
CTTCACCAACCA-39 and 59-ACGATACCGCGGGCGCTG-
TCAATG-39; cadherin 23 (EC1-2): 59-CCGGCTGCCCTTCT-
TCACCAACCA-39 and 59-ATGGTGTAGCCAATGCCCCG-
39; cadherin 24: 59-CCGCGGCTGACCTGGACT-39 and 59-
GGGCCCGGATGACCTGAA-39. Products were run on a 1%-
agarose (Fisher, Waltham, MA, USA) gel with 0.0001% ethidium-
bromide (Fisher). Bands of the expected size were registered as ‘+’
on Table S1, otherwise as ‘2’. PCR conditions were 35 cycles of:
94uC for 1.5 min, 45uC for 2 min and 72u for 3 min. PCR was
performed on a BioRad MyCycler (Hercules, CA, USA). Products
were extracted (QIAquick, Qiagen), reamplified with Phusion Taq
polymerase (Invitrogen), cloned using BLUNT Zero (Invitrogen),
and sent for sequencing at Eurofins MWG Operon (Huntsville,
AL, USA).
Immunoblotting
Confluent MCF-7 and NBF mono-cultures and 1-hour and 3-
day co-cultures were lysed in RIPA buffer (50 mM Tris, 150 mM
NaCl, 6 mM Na-deoxycholate, 1% Triton-X 100, 0.1% SDS,
2 mM EDTA, pH 8.0) containing Protease Inhibitor Cocktail III
(RPI Corp., Mt. Prospect, IL, USA). Lysates were centrifuged at
13,500 rpm at 4uC for 5 min and the supernatant was mixed with
sample buffer (0.125% bromophenol-blue in Tris-Cl, pH 6.8, 25%
glycerol, 10% SDS, 40 mM DTT) in a 1:1 ratio at 100uC for
20 mins. Proteins were separated using SDS-PAGE and trans-
ferred onto an Immobilon-P membrane (Millipore), blocked with
5% milk and labeled with the aforementioned antibodies (along
with an antibody against the cytoplasmic domain of cadherin-23
from Sigma, Cat. # SAB104883), followed by HRP-conjugated
CDH23 Mediates Heterotypic Cell Adhesion
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33289antibodies (Jackson ImmunoResearch, West Grove, PA, USA),
and visualized with SuperSignal West Femto (Thermo Scientific,
Waltham, MA, USA) and a ChemiImager 4400 (Alpha Innotech,
Randburg, South Africa). Densitometric analysis was performed
using ImageJ [27].
FACS
MCF-7s were labeled with CellTracker
TM Green (Invitrogen),
co-cultured with NBFs for 1 day, trypsinized and sorted with a BD
Biosciences FACSAria I. RT-PCR and immunoblotting was
performed as described above.
Immunohistochemistry
Immunohistochemistry was performed on a breast cancer tissue
microarray (Imgenex, San Diego, CA, USA; Cat. No IMA-100)
with two cadherin-23 antibodies in conjunction (against the EC1:
Abnova, Cat. # H00064072-A01; against the cytoplasmic
domain: Sigma, Cat. # SAB104883) followed by Vectastain Elite
ABC and DAB Substrate (Vector Laboratories, Burlingame, CA,
USA). Antigen was retrieved in a 95uC water bath in 0.01 M
sodium-citrate (pH 6.0) for 10 min and endogenous peroxidase
activity was quenched with 3% hydrogen-peroxide for 6 min.
Images were acquired at room temperature with Spot on a Zeiss
SteREO microscope with a Plan-Apo 1.56 objective and a
1.3 Mp color Diagnostic Instruments camera. ImageJ [27] was
used to acquire mean intensity values for each tissue sample, as
well as for stromal and epithelial regions of the samples. Tissue
samples that were incomplete were not included in the analysis.
Tissue samples with mean intensity 0 were given the score ‘2’.
Tissue samples with mean intensity above 0 but below 100 were
given the score ‘+’. Tissue samples with mean intensity above 100
were given the score ‘++’.
RNAi
shRNA plasmids specific for cadherin-23 and non-coding were
ordered from SA Biosciences (SureSilencing shRNA Plasmids,
Frederick, MD, USA). 4610
6 MCF-7 cells were transfected with
5 mg DNA using the Amaxa Cell Line Nucleofector Kit V (Lonza,
Cologne, Germany) in an Amaxa Nucleofector 2 (Lonza). Cells
were harvested for further experiments 24 hrs after nucleofection.
RT-PCR, immunoblotting and adhesion assays were performed as
described above.
qPCR
Confluent monocultures of MCF-7s and NBFs were trypsinized
and ,20610
4 cells were used for mRNA isolation (RNEasy with
RNAse-Free DNase set, Qiagen). qPCR was performed using the
QuantiFast SYBR Green RT-PCR kit (Qiagen) on a LightCycler
480 (Roche, Indianapolis, IN). Primers used were GAPDH
(reference gene): 59-TCTTCCAGGAGCGAGATC-39 and 59-
AGCCCCAGCCTTCTCC-39; cadherin-23: 59-CCGGCTGCC-
CTTCTTCACCAACCA-39 and 59-GGCCTCCTCCCCAGAC-
ACGCC-39. PCR conditions were 45 cycles of: 95uC for 10 sec,
50uC (GAPDH) or 52uC (cadherin-23) for 25 sec and 72uC for
7 sec (GAPDH) or 9 sec (cadherin-23). Fold change was calculated
according to [28].
Supporting Information
Figure S1 Cadherin-23 is expressed in both MCF-7 cells
and NBF cells. A) Domain structure of cadherin-23. B) PCR
comparing the expression of cadherin-23 and GAPDH (as a
control) in MCF-7 cells, NBF cells and cells co-cultured for 1 hour
or 3 days. C) Immunoblot showing protein expression of cadherin-
23 and a-tubulin (as a control) in MCF-7 cells, NBF cells and cells
co-cultured for 1 hour or 3 days. D) qPCR comparing the
expression of cadherin-23 in MCF-7 and NBF mono-cultures.
Fold change of cadherin-23 for NBF mono-cultures was compared
to that of MCF-7 mono-cultures, which was set as 1. Error bars
represent standard error from three independent experiments.
Asterisk denotes statistically significant difference (student’s t-test,
p,0.01).
(TIF)
Figure S2 Cadherin localization at homotypic and
heterotypic cell-cell contacts. Three-day co-cultures labeled
with antibodies to the noted cadherins (green) and b-catenin (red).
Nuclei were labeled with DAPI (blue). A) E-cadherin is localized at
homotypic adhesion sites (arrow) between MCF-7 cells, and shows
partial localization at heterotypic adhesion sites (arrowhead)
between an MCF-7 cell and a fibroblast (asterisk). B) N-cadherin
is localized at homotypic adhesion sites (arrow) between fibroblasts
(asterisks), and shows partial localization at heterotypic adhesion
sites (arrowhead). C) P-cadherin is localized only at adhesion sites
(arrows) between MCF-7 cells (asterisks), and not at heterotypic
adhesion sites (arrowhead). D) OB-cadherin localizes at adhesion
sites (arrow) between fibroblasts (asterisk), but not at heterotypic
adhesion sites (arrowhead). Scale=10 mm.
(TIF)
Table S1 Cadherin Expression. Expression, as determined by
RT-PCR, of various cadherin family members in MCF-7 cell
cultures, NBF cultures, and co-cultures grown for one hour (1 h)
or three days (3 d). The first column shows the most common
names of the cadherins tested. + indicates expression, and 2
indicates that expression was not detected by PCR.
(DOC)
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